STOCKRETAIL-DRUG STORES AND PROPRIETARY STORESUpdated 2026-06-14
Here’s whether CVS HEALTH CORPORATION (CVS) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+5.89% over 10 days); strong 1-year return of +53.7%; 3-month momentum positive (+34.4%). Concerns: RSI 71 — overbought, elevated pullback risk. Currently 0.8% off its 52-week high. Score: +5/7.
CVS is in a confirmed uptrend, trading above both its 50-day ($86.84) and 200-day ($79.68) moving averages. With an RSI of 71.0, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +53.7% compares to +22.9% for SPY (beat the market by 30.8%).
$10,000 invested 1 year ago→ $15,367 today
vs. S&P 500 (SPY) — same period beat market by 30.8%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($79.68)
✓Above 50-day MA ($86.84)
!RSI(14) neutral zone (30–70) — currently 71.0
✓Positive return (+53.7%)
✓Within 10% of period high (−0.8%)
Period Range $101.96
$58.50$102.77
RSI (14) 71.0
0 · OversoldOverbought · 100
Key Metrics
Price$101.96
Period Return+53.7%
Period High$102.77
Period Low$58.50
Drawdown−0.8%
MA-50$86.84
MA-200$79.68
RSI (14)71.0
Avg Volume (30d)8.8M
vs. SPYbeat by 30.8%
Return Rank#325 of 1246
Trend Signals
Price is above the 200-day moving average ($79.68)